mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.07 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.07 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |